CoChat
Sign Up
Cited by 43

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Expression of the HPV E7 Oncoprotein Mimics but Does Not Evoke a p53-Dependent Cellular DNA Damage Response Pathway

Jones, D.Leanne, Thompson, David A., Suh-Bürgmann, Elizabeth, Grace, Miranda, Münger, Karl·1999·Virology
DOI 10.1006/viro.1999.9733
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/viro.1999.9733

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 60

  1. Alani, 1998, Alterations in cyclin-dependent kinase 2 function during differentiation of primary human keratinocytes, Mol. Carcinog., 23, 226, 10.1002/(SICI)1098-2744(199812)23:4<226::AID-MC5>3.0.CO;2-N · DOI
  2. Almasan, 1995, Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis, Proc. Natl. Acad. Sci. USA, 92, 5436, 10.1073/pnas.92.12.5436 · DOI
  3. An, 1996, Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate, Cancer Res., 56, 438
  4. Bates, 1998, p14ARF links the tumour suppressors RB and p53, Nature, 395, 124, 10.1038/25867 · DOI · Paper page
  5. Berezutskaya, 1997, The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome, J. Biol. Chem., 272, 30135, 10.1074/jbc.272.48.30135 · DOI
  6. Boyer, 1996, E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway, Cancer Res., 56, 4620
  7. Cayrol, 1998, Interaction with cyclin-dependent kinases and PCNA modulates proteasome- dependent degradation of p21, Oncogene, 17, 2437, 10.1038/sj.onc.1202189 · DOI
  8. Chellappan, 1992, Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product, Proc. Natl. Acad. Sci. USA, 89, 4549, 10.1073/pnas.89.10.4549 · DOI
  9. Chiou, 1997, p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis, J. Virol., 71, 3515, 10.1128/jvi.71.5.3515-3525.1997 · DOI
  10. Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 · DOI
  11. Cryns, 1998, Proteases to die for, Genes Dev., 12, 1551, 10.1101/gad.12.11.1551 · DOI
  12. Davies, 1992, Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants, J. Gen. Virol., 73, 2135, 10.1099/0022-1317-73-8-2135 · DOI
  13. de Stanchina, 1998, E1A signaling to p53 involves the p19(ARF) tumor suppressor, Genes Dev., 12, 2434, 10.1101/gad.12.15.2434 · DOI
  14. Demers, 1994, Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7, Proc. Natl. Acad. Sci. USA, 91, 4382, 10.1073/pnas.91.10.4382 · DOI · Paper page
  15. Demers, 1994, Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene, Virology, 198, 169, 10.1006/viro.1994.1019 · DOI
  16. Deng, 1995, Mice lacking p21(CIP1/WAF1) undergo normal development, but are defective in G1 checkpoint control, Cell, 82, 675, 10.1016/0092-8674(95)90039-X · DOI · Paper page
  17. Dyson, 1992, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins, J. Virol., 66, 6893, 10.1128/jvi.66.12.6893-6902.1992 · DOI · Paper page
  18. El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
  19. El-Deiry, 1994, Waf1/Cip1 is induced in p53-mediated G(1) arrest and apoptosis, Cancer Res., 54, 1169
  20. Feinberg, 1983, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem., 132, 6, 10.1016/0003-2697(83)90418-9 · DOI
  21. Funk, 1997, Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein, Genes Dev., 11, 2090, 10.1101/gad.11.16.2090 · DOI · Paper page
  22. Gottlieb, 1994, Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal, EMBO J., 13, 1368, 10.1002/j.1460-2075.1994.tb06390.x · DOI
  23. Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  24. Haaskogan, 1995, Inhibition of apoptosis by the retinoblastoma gene product, EMBO J., 14, 461, 10.1002/j.1460-2075.1995.tb07022.x · DOI
  25. Halbert, 1991, The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells, J. Virol., 65, 473, 10.1128/jvi.65.1.473-478.1991 · DOI · Paper page
  26. Harper, 1993, The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell, 75, 805, 10.1016/0092-8674(93)90499-G · DOI · Paper page
  27. Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 · DOI · Paper page
  28. Haupt, 1995, p53-mediated apoptosis in HeLa cells can be overcome by excess pRB, Oncogene, 10, 1563
  29. Janicke, 1996, Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis, EMBO J., 15, 6969, 10.1002/j.1460-2075.1996.tb01089.x · DOI
  30. Jian, 1998, Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes, Oncogene, 17, 2027, 10.1038/sj.onc.1202142 · DOI · Paper page
  31. Jones, 1997, The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2, Genes Dev., 11, 2101, 10.1101/gad.11.16.2101 · DOI · Paper page
  32. Jones, 1996, Interactions of the human papillomavirus E7 protein with cell cycle regulators, Semin. Cancer Biol., 7, 327, 10.1006/scbi.1996.0042 · DOI
  33. Jones, 1997, Analysis of the p53- mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein, J. Virol., 71, 2905, 10.1128/jvi.71.4.2905-2912.1997 · DOI · Paper page
  34. Jones, 1997, Destabilization of the RB tumor suppressor and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis, Virology, 239, 97, 10.1006/viro.1997.8851 · DOI · Paper page
  35. Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
  36. Levine, 1997, p53, cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  37. Macleod, 1996, Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system, EMBO J., 15, 6178, 10.1002/j.1460-2075.1996.tb01006.x · DOI · Paper page
  38. Macleod, 1995, p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage, Genes Dev., 9, 935, 10.1101/gad.9.8.935 · DOI
  39. Maki, 1997, Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation, Mol. Cell Biol., 17, 355, 10.1128/MCB.17.1.355 · DOI
  40. Miller, 1989, Improved retroviral vectors for gene transfer and expression, BioTechniques, 7, 980
  41. Morgenstern, 1990, Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line, Nucleic Acids Res., 18, 3587, 10.1093/nar/18.12.3587 · DOI
  42. Nichols, 1977, Characterization of a new human diploid cell strain, IMR-90, Science, 196, 60, 10.1126/science.841339 · DOI
  43. Pagano, 1992, Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells, Oncogene, 7, 1681
  44. Samuelson, 1997, Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins, Proc. Natl. Acad. Sci. USA, 94, 12094, 10.1073/pnas.94.22.12094 · DOI
  45. Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  46. Shan, 1994, The transcription factor E2F-1 mediates the autoregulation of RB gene expression, Mol. Cell Biol., 14, 299
  47. Slebos, 1994, p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein, Proc. Natl. Acad. Sci. USA, 91, 5320, 10.1073/pnas.91.12.5320 · DOI
  48. Stott, 1998, The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2, EMBO J., 17, 5001, 10.1093/emboj/17.17.5001 · DOI
  49. Tan, 1998, The caspase-RB connection in cell death, Trends Cell Biol., 8, 116, 10.1016/S0962-8924(97)01208-7 · DOI
  50. Tang, 1998, Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53, J. Biol. Chem., 273, 29156, 10.1074/jbc.273.44.29156 · DOI
  51. Thomas, 1998, Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint, J. Virol., 72, 1131, 10.1128/JVI.72.2.1131-1137.1998 · DOI
  52. Vousden, 1993, HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53, Oncogene, 8, 1697
  53. Wang, 1996, Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis, Oncogene, 12, 2731
  54. Wazer, 1995, Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7, Proc. Natl. Acad. Sci. USA, 92, 3687, 10.1073/pnas.92.9.3687 · DOI
  55. Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 · DOI · Paper page
  56. Weinberg, 1997, The cat and mouse games that genes, viruses, and cells play, Cell, 88, 573, 10.1016/S0092-8674(00)81897-8 · DOI
  57. White, 1994, Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins, Genes Dev., 8, 666, 10.1101/gad.8.6.666 · DOI
  58. Zhang, 1998, ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell, 92, 725, 10.1016/S0092-8674(00)81401-4 · DOI · Paper page
  59. Zhu, 1995, p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F, Genes Dev., 9, 1740, 10.1101/gad.9.14.1740 · DOI
  60. zur Hausen, 1996, Papillomavirus infections—A major cause of human cancers, Biochim. Biophys. Acta, 1288, F55

Cited by

Metadata

Authors
Jones, D. L., Thompson, D. A., Suh-Bürgmann, E., Grace, M., & Münger, K.
Venue
Virology
Publisher
Elsevier BV
Published
1999-06
Volume
258
Issue
2
Pages
406-414
ISSN
0042-6822
DOI
10.1006/viro.1999.9733
Cited by
43
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review